Haemonetics Corporation (HAE)

Recent Material Events for Haemonetics Corporation
Date Description
Oct 29, 2012 On October 29, 2012, Haemonetics Corporation (the “Company”) issued a press release announcing financial results for the second quarter ended September 29, 2012. A copy of the release is furnished with this report as exhibit 99.1.
Oct 29, 2012 On October 29, 2012, Haemonetics Corporation (the “Company”) issued a press release announcing financial results for the second quarter ended September 29, 2012. A copy of the release is furnished with this report as exhibit 99.1.
Oct 09, 2012 The Company is furnishing herewith as Exhibit 99.1 the following Unaudited Pro Forma Condensed Combined Financial Information prepared to give effect to the Company's acquisition of the whole blood business. The pro forma financial statements include
Sep 27, 2012 On September 17, 2012, Haemonetics Corporation issued a press release regarding the Hemerus Medical, LLC acquisition. The press release is attached as Exhibit 99.1 to this Current Report and is incorporated herein by this reference.
Aug 07, 2012 On August 1, 2012, we completed the acquisition from Pall Corporation (“Pall”) of substantially all of the assets relating to its blood collection, filtration, processing, storage and re-infusion product lines, and all of the outstanding
Aug 07, 2012 On August 1, 2012, we completed the acquisition from Pall Corporation (“Pall”) of substantially all of the assets relating to its blood collection, filtration, processing, storage and re-infusion product lines, and all of the outstanding
Aug 02, 2012 On August 1, 2012, Haemonetics Corporation (the “Company”) issued a press release announcing financial results for the first quarter ended June 30, 2012. A copy of the release is furnished with this report as exhibit 99.1.
Aug 02, 2012 On August 1, 2012, Haemonetics Corporation (the “Company”) issued a press release announcing financial results for the first quarter ended June 30, 2012. A copy of the release is furnished with this report as exhibit 99.1.
Aug 02, 2012 On July 27, 2012, the Board of Directors of Haemonetics Corporation (the “Company”) adopted the Haemonetics Corporation Non-Qualified Deferred Compensation Plan (the “Plan”). The Plan is a nonqualified deferred compensation pl
May 22, 2012 Market for the Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities